Skip to content

Abivax

  • EN
  • FR
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
  • EN
  • FR

News & Events

Press Coverage

  • 2023
  • 2022
  • 2021
  • 2020
  • 2019

Süddeutsche Zeitung

June 5, 2020

Covid-19-Medikament ABX464 wird in Deutschland getestet

Deutsche Welle

May 28, 2020

Radio interview: A miracle from France?

Medi-Sphere

May 26, 2020

L’Allemagne accepte un essai clinique autour de l’ABX464, nouvelle molécule prometteuse

Rotenburger Rundschau

May 26, 2020

Corona-Situation hat herbe Auswirkungen auf Deutsche – Weitere Fälle nach Ausbruch in Lokal

Berliner Zeitung

May 26, 2020

Covid-19-Medikament ABX464 wird in Deutschland getestet

  • 1
  • …
  • 20
  • 21
  • 22
  • 23
  • 24
  • …
  • 46

References available upon request.

© 2025 All rights reserved by Abivax 07/2024 Privacy and Terms of Use
Consent Preferences
  • About Abivax
    • Our Mission
    • Company History
    • Our Leadership
    • Contact Us
  • Our Science
    • Novel MOA
    • Obefazimod
  • Our Research
  • Our Pipeline
  • Publications
  • Investors
    • Overview
    • Press Releases
    • News
    • Share Price
    • Investor Documents
    • General Meeting
    • Corporate Presentation
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn